img

Global Organoid Biobank Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Organoid Biobank Market Insights, Forecast to 2034

Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
Market Analysis and InsightsGlobal Organoid Biobank Market
Global Organoid Biobank market is expected to reach to US$ 141 million in 2023, with a positive growth of %, compared with US$ 121 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Organoid Biobank industry is evaluated to reach US$ 390.4 million in 2033. The CAGR will be 18.5% during 2023 to 2033.
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Report Covers
This report presents an overview of global Organoid Biobank market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Organoid Biobank market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


FRANKFURT CANCER INSTITUTE
Merck
Crown Bioscience
HUB Organoids
Cancer Research UK Convergence Science Centre
Thermo Fisher Scientific
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
Amsbio
Cellesce
DefiniGEN
3Dnamics Inc.
Organoid Therapeutics
InSphero
AIVITA Biomedical
JangoBio
Segment by Type
Tissue Derived Organoids
Pluripotent Stem Cell-derived Organoids

Segment by Application


Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Organoid Biobank introduction, etc. Organoid Biobank Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Organoid Biobank
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organoid Biobank Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Tissue Derived Organoids
1.2.3 Pluripotent Stem Cell-derived Organoids
1.3 Market by Application
1.3.1 Global Organoid Biobank Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Research Organizations
1.3.4 Academics and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoid Biobank Market Perspective (2018-2033)
2.2 Global Organoid Biobank Growth Trends by Region
2.2.1 Organoid Biobank Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Organoid Biobank Historic Market Size by Region (2018-2023)
2.2.3 Organoid Biobank Forecasted Market Size by Region (2024-2033)
2.3 Organoid Biobank Market Dynamics
2.3.1 Organoid Biobank Industry Trends
2.3.2 Organoid Biobank Market Drivers
2.3.3 Organoid Biobank Market Challenges
2.3.4 Organoid Biobank Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Organoid Biobank by Players
3.1.1 Global Organoid Biobank Revenue by Players (2018-2023)
3.1.2 Global Organoid Biobank Revenue Market Share by Players (2018-2023)
3.2 Global Organoid Biobank Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Organoid Biobank, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Organoid Biobank Market Concentration Ratio
3.4.1 Global Organoid Biobank Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organoid Biobank Revenue in 2022
3.5 Global Key Players of Organoid Biobank Head office and Area Served
3.6 Global Key Players of Organoid Biobank, Product and Application
3.7 Global Key Players of Organoid Biobank, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Organoid Biobank Breakdown Data by Type
4.1 Global Organoid Biobank Historic Market Size by Type (2018-2023)
4.2 Global Organoid Biobank Forecasted Market Size by Type (2024-2033)
5 Organoid Biobank Breakdown Data by Application
5.1 Global Organoid Biobank Historic Market Size by Application (2018-2023)
5.2 Global Organoid Biobank Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Organoid Biobank Market Size (2018-2033)
6.2 North America Organoid Biobank Market Size by Type
6.2.1 North America Organoid Biobank Market Size by Type (2018-2023)
6.2.2 North America Organoid Biobank Market Size by Type (2024-2033)
6.2.3 North America Organoid Biobank Market Share by Type (2018-2033)
6.3 North America Organoid Biobank Market Size by Application
6.3.1 North America Organoid Biobank Market Size by Application (2018-2023)
6.3.2 North America Organoid Biobank Market Size by Application (2024-2033)
6.3.3 North America Organoid Biobank Market Share by Application (2018-2033)
6.4 North America Organoid Biobank Market Size by Country
6.4.1 North America Organoid Biobank Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Organoid Biobank Market Size by Country (2018-2023)
6.4.3 North America Organoid Biobank Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Organoid Biobank Market Size (2018-2033)
7.2 Europe Organoid Biobank Market Size by Type
7.2.1 Europe Organoid Biobank Market Size by Type (2018-2023)
7.2.2 Europe Organoid Biobank Market Size by Type (2024-2033)
7.2.3 Europe Organoid Biobank Market Share by Type (2018-2033)
7.3 Europe Organoid Biobank Market Size by Application
7.3.1 Europe Organoid Biobank Market Size by Application (2018-2023)
7.3.2 Europe Organoid Biobank Market Size by Application (2024-2033)
7.3.3 Europe Organoid Biobank Market Share by Application (2018-2033)
7.4 Europe Organoid Biobank Market Size by Country
7.4.1 Europe Organoid Biobank Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Organoid Biobank Market Size by Country (2018-2023)
7.4.3 Europe Organoid Biobank Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Organoid Biobank Market Size (2018-2033)
8.2 China Organoid Biobank Market Size by Type
8.2.1 China Organoid Biobank Market Size by Type (2018-2023)
8.2.2 China Organoid Biobank Market Size by Type (2024-2033)
8.2.3 China Organoid Biobank Market Share by Type (2018-2033)
8.3 China Organoid Biobank Market Size by Application
8.3.1 China Organoid Biobank Market Size by Application (2018-2023)
8.3.2 China Organoid Biobank Market Size by Application (2024-2033)
8.3.3 China Organoid Biobank Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Organoid Biobank Market Size (2018-2033)
9.2 Asia Organoid Biobank Market Size by Type
9.2.1 Asia Organoid Biobank Market Size by Type (2018-2023)
9.2.2 Asia Organoid Biobank Market Size by Type (2024-2033)
9.2.3 Asia Organoid Biobank Market Share by Type (2018-2033)
9.3 Asia Organoid Biobank Market Size by Application
9.3.1 Asia Organoid Biobank Market Size by Application (2018-2023)
9.3.2 Asia Organoid Biobank Market Size by Application (2024-2033)
9.3.3 Asia Organoid Biobank Market Share by Application (2018-2033)
9.4 Asia Organoid Biobank Market Size by Region
9.4.1 Asia Organoid Biobank Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Organoid Biobank Market Size by Region (2018-2023)
9.4.3 Asia Organoid Biobank Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Organoid Biobank Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Organoid Biobank Market Size by Type
10.2.1 Middle East, Africa, and Latin America Organoid Biobank Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Organoid Biobank Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Organoid Biobank Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Organoid Biobank Market Size by Application
10.3.1 Middle East, Africa, and Latin America Organoid Biobank Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Organoid Biobank Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Organoid Biobank Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Organoid Biobank Market Size by Country
10.4.1 Middle East, Africa, and Latin America Organoid Biobank Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Organoid Biobank Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Organoid Biobank Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 FRANKFURT CANCER INSTITUTE
11.1.1 FRANKFURT CANCER INSTITUTE Company Details
11.1.2 FRANKFURT CANCER INSTITUTE Business Overview
11.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Introduction
11.1.4 FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2018-2023)
11.1.5 FRANKFURT CANCER INSTITUTE Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Organoid Biobank Introduction
11.2.4 Merck Revenue in Organoid Biobank Business (2018-2023)
11.2.5 Merck Recent Developments
11.3 Crown Bioscience
11.3.1 Crown Bioscience Company Details
11.3.2 Crown Bioscience Business Overview
11.3.3 Crown Bioscience Organoid Biobank Introduction
11.3.4 Crown Bioscience Revenue in Organoid Biobank Business (2018-2023)
11.3.5 Crown Bioscience Recent Developments
11.4 HUB Organoids
11.4.1 HUB Organoids Company Details
11.4.2 HUB Organoids Business Overview
11.4.3 HUB Organoids Organoid Biobank Introduction
11.4.4 HUB Organoids Revenue in Organoid Biobank Business (2018-2023)
11.4.5 HUB Organoids Recent Developments
11.5 Cancer Research UK Convergence Science Centre
11.5.1 Cancer Research UK Convergence Science Centre Company Details
11.5.2 Cancer Research UK Convergence Science Centre Business Overview
11.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Introduction
11.5.4 Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2018-2023)
11.5.5 Cancer Research UK Convergence Science Centre Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Organoid Biobank Introduction
11.6.4 Thermo Fisher Scientific Revenue in Organoid Biobank Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 Corning
11.7.1 Corning Company Details
11.7.2 Corning Business Overview
11.7.3 Corning Organoid Biobank Introduction
11.7.4 Corning Revenue in Organoid Biobank Business (2018-2023)
11.7.5 Corning Recent Developments
11.8 STEMCELL Technologies
11.8.1 STEMCELL Technologies Company Details
11.8.2 STEMCELL Technologies Business Overview
11.8.3 STEMCELL Technologies Organoid Biobank Introduction
11.8.4 STEMCELL Technologies Revenue in Organoid Biobank Business (2018-2023)
11.8.5 STEMCELL Technologies Recent Developments
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza Organoid Biobank Introduction
11.9.4 Lonza Revenue in Organoid Biobank Business (2018-2023)
11.9.5 Lonza Recent Developments
11.10 Prellis Biologics
11.10.1 Prellis Biologics Company Details
11.10.2 Prellis Biologics Business Overview
11.10.3 Prellis Biologics Organoid Biobank Introduction
11.10.4 Prellis Biologics Revenue in Organoid Biobank Business (2018-2023)
11.10.5 Prellis Biologics Recent Developments
11.11 Amsbio
11.11.1 Amsbio Company Details
11.11.2 Amsbio Business Overview
11.11.3 Amsbio Organoid Biobank Introduction
11.11.4 Amsbio Revenue in Organoid Biobank Business (2018-2023)
11.11.5 Amsbio Recent Developments
11.12 Cellesce
11.12.1 Cellesce Company Details
11.12.2 Cellesce Business Overview
11.12.3 Cellesce Organoid Biobank Introduction
11.12.4 Cellesce Revenue in Organoid Biobank Business (2018-2023)
11.12.5 Cellesce Recent Developments
11.13 DefiniGEN
11.13.1 DefiniGEN Company Details
11.13.2 DefiniGEN Business Overview
11.13.3 DefiniGEN Organoid Biobank Introduction
11.13.4 DefiniGEN Revenue in Organoid Biobank Business (2018-2023)
11.13.5 DefiniGEN Recent Developments
11.14 3Dnamics Inc.
11.14.1 3Dnamics Inc. Company Details
11.14.2 3Dnamics Inc. Business Overview
11.14.3 3Dnamics Inc. Organoid Biobank Introduction
11.14.4 3Dnamics Inc. Revenue in Organoid Biobank Business (2018-2023)
11.14.5 3Dnamics Inc. Recent Developments
11.15 Organoid Therapeutics
11.15.1 Organoid Therapeutics Company Details
11.15.2 Organoid Therapeutics Business Overview
11.15.3 Organoid Therapeutics Organoid Biobank Introduction
11.15.4 Organoid Therapeutics Revenue in Organoid Biobank Business (2018-2023)
11.15.5 Organoid Therapeutics Recent Developments
11.16 InSphero
11.16.1 InSphero Company Details
11.16.2 InSphero Business Overview
11.16.3 InSphero Organoid Biobank Introduction
11.16.4 InSphero Revenue in Organoid Biobank Business (2018-2023)
11.16.5 InSphero Recent Developments
11.17 AIVITA Biomedical
11.17.1 AIVITA Biomedical Company Details
11.17.2 AIVITA Biomedical Business Overview
11.17.3 AIVITA Biomedical Organoid Biobank Introduction
11.17.4 AIVITA Biomedical Revenue in Organoid Biobank Business (2018-2023)
11.17.5 AIVITA Biomedical Recent Developments
11.18 JangoBio
11.18.1 JangoBio Company Details
11.18.2 JangoBio Business Overview
11.18.3 JangoBio Organoid Biobank Introduction
11.18.4 JangoBio Revenue in Organoid Biobank Business (2018-2023)
11.18.5 JangoBio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Organoid Biobank Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Tissue Derived Organoids
Table 3. Key Players of Pluripotent Stem Cell-derived Organoids
Table 4. Global Organoid Biobank Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Organoid Biobank Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Organoid Biobank Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Organoid Biobank Market Share by Region (2018-2023)
Table 8. Global Organoid Biobank Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Organoid Biobank Market Share by Region (2024-2033)
Table 10. Organoid Biobank Market Trends
Table 11. Organoid Biobank Market Drivers
Table 12. Organoid Biobank Market Challenges
Table 13. Organoid Biobank Market Restraints
Table 14. Global Organoid Biobank Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Organoid Biobank Revenue Share by Players (2018-2023)
Table 16. Global Top Organoid Biobank by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoid Biobank as of 2022)
Table 17. Global Organoid Biobank Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Organoid Biobank Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Organoid Biobank, Headquarters and Area Served
Table 20. Global Key Players of Organoid Biobank, Product and Application
Table 21. Global Key Players of Organoid Biobank, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Organoid Biobank Revenue Market Share by Type (2018-2023)
Table 25. Global Organoid Biobank Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Organoid Biobank Revenue Market Share by Type (2024-2033)
Table 27. Global Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Organoid Biobank Revenue Share by Application (2018-2023)
Table 29. Global Organoid Biobank Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Organoid Biobank Revenue Share by Application (2024-2033)
Table 31. North America Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Organoid Biobank Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Organoid Biobank Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Organoid Biobank Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Organoid Biobank Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Organoid Biobank Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Organoid Biobank Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Organoid Biobank Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Organoid Biobank Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Organoid Biobank Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Organoid Biobank Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Organoid Biobank Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Organoid Biobank Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Organoid Biobank Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Organoid Biobank Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Organoid Biobank Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Organoid Biobank Market Size by Country (2024-2033) & (US$ Million)
Table 63. FRANKFURT CANCER INSTITUTE Company Details
Table 64. FRANKFURT CANCER INSTITUTE Business Overview
Table 65. FRANKFURT CANCER INSTITUTE Organoid Biobank Product
Table 66. FRANKFURT CANCER INSTITUTE Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 67. FRANKFURT CANCER INSTITUTE Recent Developments
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Organoid Biobank Product
Table 71. Merck Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 72. Merck Recent Developments
Table 73. Crown Bioscience Company Details
Table 74. Crown Bioscience Business Overview
Table 75. Crown Bioscience Organoid Biobank Product
Table 76. Crown Bioscience Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 77. Crown Bioscience Recent Developments
Table 78. HUB Organoids Company Details
Table 79. HUB Organoids Business Overview
Table 80. HUB Organoids Organoid Biobank Product
Table 81. HUB Organoids Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 82. HUB Organoids Recent Developments
Table 83. Cancer Research UK Convergence Science Centre Company Details
Table 84. Cancer Research UK Convergence Science Centre Business Overview
Table 85. Cancer Research UK Convergence Science Centre Organoid Biobank Product
Table 86. Cancer Research UK Convergence Science Centre Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 87. Cancer Research UK Convergence Science Centre Recent Developments
Table 88. Thermo Fisher Scientific Company Details
Table 89. Thermo Fisher Scientific Business Overview
Table 90. Thermo Fisher Scientific Organoid Biobank Product
Table 91. Thermo Fisher Scientific Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 92. Thermo Fisher Scientific Recent Developments
Table 93. Corning Company Details
Table 94. Corning Business Overview
Table 95. Corning Organoid Biobank Product
Table 96. Corning Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 97. Corning Recent Developments
Table 98. STEMCELL Technologies Company Details
Table 99. STEMCELL Technologies Business Overview
Table 100. STEMCELL Technologies Organoid Biobank Product
Table 101. STEMCELL Technologies Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 102. STEMCELL Technologies Recent Developments
Table 103. Lonza Company Details
Table 104. Lonza Business Overview
Table 105. Lonza Organoid Biobank Product
Table 106. Lonza Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 107. Lonza Recent Developments
Table 108. Prellis Biologics Company Details
Table 109. Prellis Biologics Business Overview
Table 110. Prellis Biologics Organoid Biobank Product
Table 111. Prellis Biologics Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 112. Prellis Biologics Recent Developments
Table 113. Amsbio Company Details
Table 114. Amsbio Business Overview
Table 115. Amsbio Organoid Biobank Product
Table 116. Amsbio Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 117. Amsbio Recent Developments
Table 118. Cellesce Company Details
Table 119. Cellesce Business Overview
Table 120. Cellesce Organoid Biobank Product
Table 121. Cellesce Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 122. Cellesce Recent Developments
Table 123. DefiniGEN Company Details
Table 124. DefiniGEN Business Overview
Table 125. DefiniGEN Organoid Biobank Product
Table 126. DefiniGEN Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 127. DefiniGEN Recent Developments
Table 128. 3Dnamics Inc. Company Details
Table 129. 3Dnamics Inc. Business Overview
Table 130. 3Dnamics Inc. Organoid Biobank Product
Table 131. 3Dnamics Inc. Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 132. 3Dnamics Inc. Recent Developments
Table 133. Organoid Therapeutics Company Details
Table 134. Organoid Therapeutics Business Overview
Table 135. Organoid Therapeutics Organoid Biobank Product
Table 136. Organoid Therapeutics Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 137. Organoid Therapeutics Recent Developments
Table 138. InSphero Company Details
Table 139. InSphero Business Overview
Table 140. InSphero Organoid Biobank Product
Table 141. InSphero Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 142. InSphero Recent Developments
Table 143. AIVITA Biomedical Company Details
Table 144. AIVITA Biomedical Business Overview
Table 145. AIVITA Biomedical Organoid Biobank Product
Table 146. AIVITA Biomedical Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 147. AIVITA Biomedical Recent Developments
Table 148. JangoBio Company Details
Table 149. JangoBio Business Overview
Table 150. JangoBio Organoid Biobank Product
Table 151. JangoBio Revenue in Organoid Biobank Business (2018-2023) & (US$ Million)
Table 152. JangoBio Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Organoid Biobank Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Organoid Biobank Market Share by Type: 2022 VS 2033
Figure 3. Tissue Derived Organoids Features
Figure 4. Pluripotent Stem Cell-derived Organoids Features
Figure 5. Global Organoid Biobank Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Organoid Biobank Market Share by Application: 2022 VS 2033
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Contract Research Organizations Case Studies
Figure 9. Academics and Research Institutes Case Studies
Figure 10. Organoid Biobank Report Years Considered
Figure 11. Global Organoid Biobank Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Organoid Biobank Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Organoid Biobank Market Share by Region: 2022 VS 2033
Figure 14. Global Organoid Biobank Market Share by Players in 2022
Figure 15. Global Top Organoid Biobank Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoid Biobank as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Organoid Biobank Revenue in 2022
Figure 17. North America Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Organoid Biobank Market Share by Type (2018-2033)
Figure 19. North America Organoid Biobank Market Share by Application (2018-2033)
Figure 20. North America Organoid Biobank Market Share by Country (2018-2033)
Figure 21. United States Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Organoid Biobank Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Organoid Biobank Market Share by Type (2018-2033)
Figure 25. Europe Organoid Biobank Market Share by Application (2018-2033)
Figure 26. Europe Organoid Biobank Market Share by Country (2018-2033)
Figure 27. Germany Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Organoid Biobank Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Organoid Biobank Market Share by Type (2018-2033)
Figure 35. China Organoid Biobank Market Share by Application (2018-2033)
Figure 36. Asia Organoid Biobank Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Organoid Biobank Market Share by Type (2018-2033)
Figure 38. Asia Organoid Biobank Market Share by Application (2018-2033)
Figure 39. Asia Organoid Biobank Market Share by Region (2018-2033)
Figure 40. Japan Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Organoid Biobank Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Organoid Biobank Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Organoid Biobank Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Organoid Biobank Market Share by Country (2018-2033)
Figure 50. Brazil Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Organoid Biobank Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. FRANKFURT CANCER INSTITUTE Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 58. Crown Bioscience Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 59. HUB Organoids Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 60. Cancer Research UK Convergence Science Centre Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 62. Corning Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 63. STEMCELL Technologies Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 64. Lonza Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 65. Prellis Biologics Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 66. Amsbio Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 67. Cellesce Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 68. DefiniGEN Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 69. 3Dnamics Inc. Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 70. Organoid Therapeutics Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 71. InSphero Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 72. AIVITA Biomedical Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 73. JangoBio Revenue Growth Rate in Organoid Biobank Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries